Olivier Tomat is, since 2019, the Executive Director of Genopole Entreprises, where he oversees and manages various programs to spur and support the growth of biotechnology companies, both in the field of innovative therapies and medical biotechnologies, and in the bioeconomy sector, where much of Genopole’s efforts have recently been dedicated to the alternative proteins space.
He has spent most of the last twenty years designing and managing startup incubation and acceleration programs in France and abroad and was, last before Genopole, Innovation Expert for the French Government at the University of California, Berkeley.